Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    11806971 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells
Condition: Hematologic Diseases
Intervention:
2 Recruiting Busulfan and Melphalan Conditioning in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: BUSULFEX®;   Drug: Alkeran®

Indicates status has not been verified in more than two years